If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Share News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

Wed, 13th Dec 2023 21:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

British Smaller Cos VCT PLC and VCT 2 - Leeds, England-based venture capital trusts - Confirm the addition of an over-allotment facility of GBP25 million to their subscription offer, following its launch in September. Add that they have received applications approaching GBP60 million so far, with the deadline for applications on March 28, 2024. Notes subscription was initially launched to raise GBP65 million.

----------

Frontier IP Group PLC - London-based intellectual property commercialisation company - Says portfolio company The Vaccine Group has appointed three animal health experts to its advisory board in order to support the scale-up of its herpesvirus-based platform. Says advisory board members are Merck & Co Inc's Christophe Barnier-Quer, as well as Johan Dreesen and Vaughn Kubiak. Neil Crabb, Frontier IP Chief Executive Officer, says: "I am delighted TVG has been able to form an advisory group of such good quality. It is a testament to the potential of the Company, its vaccine platform and pipeline, and I look forward to further developments as TVG's vaccines move towards scale up and full commercialisation."

----------

DeepVerge PLC - Dublin-based environmental and life sciences firm - Says it has made progress in its discussions with potential buyers of assets and intellectual property in its Modern Water and Labskin business units. Adds that it hopes to agree on a sale in January. Says, however, that even if both asset sets are sold, the sales will not be of enough value to avoid closure or administration of the two subsidiaries. Adds that it currently has debts of GBP300,000 and is unsure whether it will have the funds to pay these debts. Says shares expected to be cancelled on December 27.

----------

Good Energy Group PLC - Wiltshire, England-based supplier of 100% renewable power and an innovator in energy services - Says investee company Zapmap, an electric vehicle charge point mapping service, has expanded its market presence to mainland Europe. Says its mapping service is now available in France, Germany, Belgium, the Netherlands and Luxembourg. Says coming months will see Zapmap open features including EV route planning and charging payments. Good Energy Chief Executive Nigel Pocklington says: "Zapmap has made significant progress over the last year as it continues to broaden and deepen its market presence in the UK and now across Europe. It continues to track with the rapidly growing electric vehicle market, which has expanded by 40% in the UK last year with the share of electric vehicles new car registrations increasing in almost all EU countries."

----------

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Launches placing to raise GBP1.6 million, via the issue of 26.3 million shares at 6.0 pence each. Adds that it will also launch a retail offer at 6.0 pence per retail share. Says retail offer is only open to existing shareholders. Notes that certain directors will also subscribe for 500,000 shares at 6.0p each. Says it will raise GBP1.9 million in total, which will be used to integrate BioBank materials form its asset acquisition from Imagen, as well as research and development.

----------

Creo Medical Group PLC - Chepstow, Wales-based medical device company - Says it has completed the first procedure using Speedboat Ultraslim. Says the product was used for a lower Gastrointestinal tract procedure in the UK, with the first European procedure expected to follow shortly. Speedboat is used to treat gastrointestinal tract diseases, including bowel, stomach and oesophagus cancers. CEO Craig Gulliford comments: "This is yet another landmark moment for Creo Medical. We know what a difference this even smaller device will make in terms of broadening access to advanced energy in endoscopy for a wider pool of clinicians. Speedboat UltraSlim is compatible with all major endoscopes, meaning clinicians can bring advanced energy to their practices, allowing more patients to be treated endoscopically, which avoids surgery and the associated secondary costs and risks."

----------

Macfarlane Group PLC - Glasgow-based supplier of packaging materials - Promotes James Baird to senior independent director.

----------

Asia Strategic Holdings Ltd - Singapore-based developer and operator of consumer businesses located in emerging Asian economies - Agrees amended loan facility with Macan Pte Ltd, increasing its loan to USD4.5 million, from USD3.0 million. Adds that the increase is in order to support its expansion of its school network. Notes that it has agreed to extend the repayment date to December 31 2027. Macan is the largest shareholder of Asia Strategic, representing 32.4%, while Asia Strategic Chief Executive Enrico Cesenni holds 35.1% of the voting rights of Macan.

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more
9 Apr 2020 15:24

Frontier IP Group Investee Alusid Launches Luxury Table Brand

Frontier IP Group Investee Alusid Launches Luxury Table Brand

Read more
1 Apr 2020 17:56

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work

Read more
13 Mar 2020 14:23

Frontier IP shares rise on progress at The Vaccine Group

(Sharecast News) - University intellectual property commercialisation company Frontier IP noted an announcement below from its portfolio company The Vaccine Group (TVG) on Friday, about the material progress it was making with its novel vaccine technology, and the start of work on a Covid-19 coronavirus vaccine for use in animals.

Read more
13 Mar 2020 12:59

Frontier IP's Vaccine Group Working On Covid-19 Vaccine For Animals

Frontier IP's Vaccine Group Working On Covid-19 Vaccine For Animals

Read more
17 Feb 2020 11:47

Frontier IP Investee Secures EU Funding For Microscope Development

Frontier IP Investee Secures EU Funding For Microscope Development

Read more
12 Feb 2020 11:39

Frontier IP Ups Stake In AI Firm Celerum Amid "Industry Interest"

Frontier IP Ups Stake In AI Firm Celerum Amid "Industry Interest"

Read more
31 Jan 2020 17:32

Frontier IP Notes First Trials Of Exscientia's OCD Drug Candidate

Frontier IP Notes First Trials Of Exscientia's OCD Drug Candidate

Read more
20 Jan 2020 12:23

Frontier IP Investee Vaccine Group Secures GBP680,000 In Funding

Frontier IP Investee Vaccine Group Secures GBP680,000 In Funding

Read more
14 Jan 2020 14:58

Frontier IP portfolio firm Fieldwork raises ?0.3m for fruit picking robot

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Tuesday that its portfolio company, Fieldwork Robotics, has raised £0.298m through an initial equity funding round.

Read more
14 Jan 2020 12:36

Frontier IP Investee Fieldwork Robotics Raises Almost GBP300,000

Frontier IP Investee Fieldwork Robotics Raises Almost GBP300,000

Read more
10 Jan 2020 15:25

Frontier IP upbeat as portfolio company partners with Bayer

(Sharecast News) - Intellectual property commercialisation company Frontier IP announced on Friday that its portfolio company Exscientia, which focuses on artificial intelligence (AI) driven drug discovery, has entered into a collaboration with Bayer focused on cardiovascular disease and oncology.

Read more
6 Nov 2019 14:38

UPDATE: Frontier IP Raises GBP3.8 Million Via Oversubscribed Placing

UPDATE: Frontier IP Raises GBP3.8 Million Via Oversubscribed Placing

Read more
6 Nov 2019 11:08

Frontier IP To Raise GBP3.5 Million As Annual Profit Rises Sharply

Frontier IP To Raise GBP3.5 Million As Annual Profit Rises Sharply

Read more
6 Nov 2019 10:52

Frontier IP profit doubles amid soaring revenues

(Sharecast News) - Frontier IP on Wednesday reported that its annual profits more than doubled after a rise in the fair value of its investments led to a leap in revenue.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.